Search by Drug Name or NDC

    NDC 61919-0641-20 MECLIZINE HCL 25 mg/251 Details

    MECLIZINE HCL 25 mg/251

    MECLIZINE HCL is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by DIRECTRX. The primary component is MECLIZINE HYDROCHLORIDE.

    Product Information

    NDC 61919-0641
    Product ID 61919-641_86313229-5407-cd4d-e053-2991aa0a78f3
    Associated GPIs 50200050000510
    GCN Sequence Number 004736
    GCN Sequence Number Description meclizine HCl TAB CHEW 25 MG ORAL
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 18312
    HICL Sequence Number 001975
    HICL Sequence Number Description MECLIZINE HCL
    Brand/Generic Generic
    Proprietary Name MECLIZINE HCL
    Proprietary Name Suffix n/a
    Non-Proprietary Name MECLIZINE HCL
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, CHEWABLE
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/251
    Substance Name MECLIZINE HYDROCHLORIDE
    Labeler Name DIRECTRX
    Pharmaceutical Class Antiemetic [EPC], Emesis Suppression [PE]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part336
    Listing Certified Through 2023-12-31

    Package

    NDC 61919-0641-20 (61919064120)

    NDC Package Code 61919-641-20
    Billing NDC 61919064120
    Package 20 TABLET, CHEWABLE in 1 BOTTLE (61919-641-20)
    Marketing Start Date 2019-04-10
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 862e048c-eb73-a3b7-e053-2991aa0accf4 Details

    Revised: 4/2019